PATENT CLAIM ANALYSIS

Application Number: 16196038
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["544", "331000"]

Abstract:
Disclosed are compounds of formula (I), pharmaceutical compositions comprising such compounds and methods/uses of using the same, for example, for treating a JAK-related disorder, such as cancer, cancer cachexia or an immune disorder: wherein R 1  is methyl or ethyl; R 2  is selected from methyl, ethyl, methoxy and ethoxy; R 3  is selected from hydrogen, chlorine, fluorine, bromine and methyl; R 4  is selected from methyl, ethyl and —CH 2 OCH 3 ; R 5  and R 6  are each individually methyl or hydrogen; and R 7  is selected from methyl, ethyl, —(CH 2 ) 2 OH and —(CH 2 ) 2 OCH 3 , or a pharmaceutically acceptable salt thereof.

Claim (Index 22):
The solvate form of  claim 10 , which has an XRPD pattern comprising at least three specific peaks expressed as 2\u03b8 (\u00b10.2\u00b0) selected from 16.3\u00b0, 23.9\u00b0, 24.4\u00b0, 25.1\u00b0, 28.1\u00b0, 29.3\u00b0, 31.8\u00b0, 32.7\u00b0, 37.5\u00b0.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 98.0
- Lexical Diversity: 2.14062
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15272554', '15601324', '13592389', '14326051', '15269485']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7953887506282264
- 35 USC 102 Novelty (BERT): 0.6317527840395233
- Combined Prediction Score: 0.7790251539693561
- Mean Citation Score: 504.14294200000006
- Max Citation Score: 749.4870599999997
- Similarity Product: 518.3220839681767

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test